Skip to main content
. 2019 Oct 22;7(11):E1327–E1332. doi: 10.1055/a-0957-3005

Table 2. Final diagnosis of propensity-matched patients.

Final diagnosis n (%)
Adenocarcinoma 141 (74.2 %)
NET  10 (5.3 %)
SPN  10 (5.3 %)
Metastatic pancreatic tumor   4 (2.1 %)
Acinar cell carcinoma   3 (1.6 %)
Benign lesions  22 (11.6 %)
Overall 190 (100 %)

n, number of lesions; NET, neuroendocrine tumor; SPN, solid pseudopapillary neoplasm